{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:57:03Z","timestamp":1781139423239,"version":"3.54.1"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"Supplement_1","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The 21st International Vasculitis Workshop, held in Barcelona, Spain, from April 7 to 10, 2024, highlighted advances in pediatric vasculitis, focusing on a holistic, multidisciplinary approach. Common childhood vasculitides, including IgA Vasculitis (IgAV) and Kawasaki Disease (KD), were discussed. The Ankara 2008 criteria for IgAV, endorsed by EULAR and PReS, were evaluated for their performance in adults, showing high sensitivity but necessitating further refinement for improved specificity. Studies on genetic associations, such as Human Leukocyte Antigen (HLA) polymorphisms in IgAV, and biomarkers like S100A8\/A9, HMGB1, and RAGE, were presented. Kawasaki disease research included novel anti-apolipoprotein A-2 antibodies, showing promise in reducing coronary arteritis. Monogenic vasculitides, such as deficiency of ADA2, were addressed with new consensus-driven recommendations. The workshop underscored the importance of continued research and tailored therapeutic strategies to improve outcomes in pediatric vasculitis, paving the way for advancements in diagnosis, management, and understanding of these complex diseases.<\/jats:p>","DOI":"10.1093\/rheumatology\/keae406","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T09:17:24Z","timestamp":1741771044000},"page":"i131-i133","source":"Crossref","is-referenced-by-count":1,"title":["Highlights from the breakout session: vasculitis in paediatric rheumatology"],"prefix":"10.1093","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5274-3285","authenticated-orcid":false,"given":"Yagmur","family":"Bayindir","sequence":"first","affiliation":[{"name":"Department of Paediatric Rheumatology, Hacettepe University Faculty of Medicine , Ankara,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1728-4260","authenticated-orcid":false,"given":"Marija","family":"Jelusic","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, University Hospital Centre Zagreb, School of Medicine, University of Zagreb , Zagreb,","place":["Croatia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2883-7868","authenticated-orcid":false,"given":"Seza","family":"Ozen","sequence":"additional","affiliation":[{"name":"Department of Paediatric Rheumatology, Hacettepe University Faculty of Medicine , Ankara,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,3,12]]},"reference":[{"key":"2025031209170461700_keae406-B1","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1136\/ard.2009.116657","article-title":"EULAR\/PRINTO\/PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: final classification criteria","volume":"69","author":"Ozen","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"2025031209170461700_keae406-B2","doi-asserted-by":"crossref","first-page":"853724","DOI":"10.3389\/fped.2022.853724","article-title":"New insights and challenges associated with IgA vasculitis and IgA vasculitis with nephritis-is it time to change the paradigm of the most common systemic vasculitis in childhood?","volume":"10","author":"Jelusic","year":"2022","journal-title":"Front Pediatr"},{"key":"2025031209170461700_keae406-B3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1546-0096-12-50","article-title":"The presence of high mobility group box-1 and soluble receptor for advanced glycation end-products in juvenile idiopathic arthritis and juvenile systemic lupus erythematosus","volume":"12","author":"Bobek","year":"2014","journal-title":"Pediatr Rheumatol"},{"key":"2025031209170461700_keae406-B4","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1056\/NEJMoa2026834","article-title":"Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease","volume":"383","author":"Beck","year":"2020","journal-title":"N Engl J Med"},{"key":"2025031209170461700_keae406-B5","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00281-022-00918-8","article-title":"Mechanisms of vascular inflammation in deficiency of adenosine deaminase 2 (DADA2)","volume":"44","author":"Lee","year":"2022","journal-title":"Semin Immunopathol"},{"key":"2025031209170461700_keae406-B6","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/art.42354","article-title":"De novo gain-of-function variations in LYN associated with an early-onset systemic autoinflammatory disorder","volume":"75","author":"Louvrier","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"2025031209170461700_keae406-B7","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3899\/jrheum.181384","article-title":"A monogenic disease with a variety of phenotypes: deficiency of adenosine deaminase 2","volume":"47","author":"\u00d6zen","year":"2020","journal-title":"J Rheumatol"},{"key":"2025031209170461700_keae406-B8","doi-asserted-by":"crossref","first-page":"e2315894","DOI":"10.1001\/jamanetworkopen.2023.15894","article-title":"Evaluation and management of deficiency of adenosine deaminase 2: an international consensus statement","volume":"6","author":"Lee","year":"2023","journal-title":"JAMA Netw Open"},{"key":"2025031209170461700_keae406-B9","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1002\/art.39729","article-title":"Comparing presenting clinical features in 48 children with microscopic polyangiitis to 183 children who have granulomatosis with polyangiitis (Wegener's): an ARChiVe cohort study","volume":"68","author":"Cabral","year":"2016","journal-title":"Arthritis & Rheumatology"},{"key":"2025031209170461700_keae406-B10","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMoa2023386","article-title":"Avacopan for the treatment of ANCA-associated vasculitis","volume":"384","author":"Jayne","year":"2021","journal-title":"New Engl J Med"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/Supplement_1\/i131\/62374855\/keae406.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/Supplement_1\/i131\/62374855\/keae406.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T09:17:28Z","timestamp":1741771048000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/Supplement_1\/i131\/8069378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,1]]},"references-count":10,"journal-issue":{"issue":"Supplement_1","published-online":{"date-parts":[[2025,3,12]]},"published-print":{"date-parts":[[2025,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keae406","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,3]]},"published":{"date-parts":[[2025,3,1]]}}}